LPL Financial »

Entrada Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Entrada Therapeutics (TRDA) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Entrada Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Entrada Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Entrada Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2024-12-31 $954k 55k 17.29
2024-09-30 $781k 49k 15.98

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Ishares Tr Core Msci Eafe (IEFA)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Ishares Tr Core S&p Mcp Etf (IJH)
Ishares Tr Us Treas Bd Etf (GOVT)

View all positions for LPL Financial

Top funds holding Entrada Therapeutics

Baker Bros. Advisors
5AM Venture Management
MPM Asset Management
T. Rowe Price Associates
Henderson Group
BlackRock
Vanguard Group
FMR
Wellington Management Company
StepStone
TCG Crossover Management
Geode Capital Management
State Street Corporation
Northern Trust
Goldman Sachs Group

View all funds holding Entrada Therapeutics